Document Detail

Rapidly destructive Staphylococcus epidermidis endocarditis.
MedLine Citation:
PMID:  15940416     Owner:  NLM     Status:  MEDLINE    
A 29-year-old man with rapidly destructive Staphylococcus epidermidis endocarditis after mitral valve reconstruction is presented. Resistance to rifampin and teicoplanin occurred during antibiotic treatment resulting in clinical failure and valve destruction. Subsequently, the patient was successfully treated, by combining valve replacement with antibiotic therapy including quinupristin/dalfopristin, levofloxacin, and vancomycin. In conclusion, S. epidermidis can cause rapid valve destruction with large vegetations, and combination of surgery and antibiotic therapy may be necessary.
A S Zinkernagel; R F Speck; C Ruef; W Zingg; B Berger-Bachi; B Springer
Related Documents :
6607726 - Bacterial endophthalmitis after closed vitrectomy.
18444486 - Treatment alternatives for chronic rhinosinusitis persisting after ess: what to do when...
3422726 - Prophylactic penicillin versus penicillin taken at the first sign of swelling in cases ...
269236 - Lymphangioma of the tongue: medical and surgical therapy.
9843256 - Adjunctive intra-operative local anaesthesia in paediatric strabismus surgery: a random...
24287436 - Using eye movements to investigate selective attention in chronic daily headache.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Infection     Volume:  33     ISSN:  0300-8126     ISO Abbreviation:  Infection     Publication Date:  2005 Jun 
Date Detail:
Created Date:  2005-06-07     Completed Date:  2005-07-26     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0365307     Medline TA:  Infection     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  148-50     Citation Subset:  IM    
Division of Infectious Diseases and Hospital Epidemiology, University Hospital of Zurich, Raemistr. 100, 8091 Zurich, Switzerland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anti-Bacterial Agents / therapeutic use
Disease Progression
Drug Resistance, Multiple, Bacterial
Endocarditis, Bacterial / drug therapy,  microbiology*,  surgery
Staphylococcal Infections / diagnosis*,  drug therapy,  microbiology
Staphylococcus epidermidis / drug effects,  isolation & purification*
Reg. No./Substance:
0/Anti-Bacterial Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Treatment of HIV-1-associated Kaposi's sarcoma with pegylated liposomal doxorubicin and HAART simult...
Next Document:  Possibly linezolid-induced peripheral and central neurotoxicity: report of four cases.